JPRN-UMIN000037033
Completed
未知
The feasibility study for screening of early stage of lung cancer by novel urinary biomarker using protein fragments: a prospective study - The feasibility study for screening of early stage of lung cancer by novel urinary biomarker using protein fragments: a prospective study
niversity of Miyazaki0 sites120 target enrollmentJune 12, 2019
ConditionsIdiopathic pulmonary fibrosis (IPF)
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Idiopathic pulmonary fibrosis (IPF)
- Sponsor
- niversity of Miyazaki
- Enrollment
- 120
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Patients who have abnormal shadow (more than or equal to 1\.0 cm) clinicaly suspected lung cancer by high resolution CT. 2\)Patients who have proteinuria, positive urine sugar or urine occult blood in urinalysis (more than or equal to 2\+). 3\)Patients who have renal dysfunction (Serum levels of creatinine \> 2\.0 mg/dl). 4\)Patients who have alcohol or drug dependence or who are suspected to have alcohol or drug dependence. 5\)Patients who is pregnant or who is suspected to be pregnant. 6\)Patients who was enrolled another clinical trial and was prescribed a study drug within one month. 7\)Patients whose attending physicians consider to be inappropriate for this study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
Development of an early screening instrument for Autism Spectrum Disorder.Health Condition 1: F840- Autistic disorderCTRI/2022/04/041686C A Ashitha Sreelakshmi
Recruiting
Phase 1
A study evaluating the safety and efficacy of anti-CD19 CAR T in subjects with Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCTIS2022-501686-47-00Galapagos25
Active, not recruiting
Phase 1
A study evaluating the safety and efficacy of anti-CD19 CAR T in subjects with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma.EUCTR2021-003815-25-ESCellPoint B.V.45
Completed
Not Applicable
Feasibility of an Early Detection Program for Early Psychosis on a College CampusPsychosisFirst Episode PsychosisClinical High Risk for PsychosisNCT03983421University of New Mexico25
Recruiting
Phase 1
It is a study in a type of blood cancer patients. In this we will add a new medicine called Ruxolitinib in the treatment and see the results.CTRI/2021/02/031251Tata Research Administrative Council TRAC